SCHEMBL2070210

SCHEMBL2070210

CCCCC[Sn](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1028927 0.97 TSHR (0.53)
SCHEMBL1032394 0.97 TSHR (0.53)
Ammonia Solution, Strong SCHEMBL28063779 0.94 TSHR (0.50)
SCHEMBL5953560 0.89
SCHEMBL11417390 0.79 TSHR (0.47)
SCHEMBL1030809 0.76 TSHR (0.53)
SCHEMBL6275141 0.76 TSHR (0.53)
SCHEMBL2549738 0.76 TSHR (0.53)
SCHEMBL11076226 0.76 TSHR (0.53)
SCHEMBL27558855 0.76 TSHR (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117088909-A Method for producing aryltrimethylstannane compound 上海致同建设工程科技有限公司 2023-11-21 CN disclosed
CN-117088909-A Method for producing aryltrimethylstannane compound 上海致同建设工程科技有限公司 2023-11-21 CN disclosed
CN-109651378-B Micromolecule containing heptatomic ring diimide, derivative, preparation method and application thereof 长安大学 2022-02-25 CN disclosed
US-10376522-B2 Triarylmethane analogs and their use in treating cancers EMORY UNIVERSITY (US) 2019-08-13 US disclosed
US-20170000801-A1 TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS THE US GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERAN AFFAIRS 2017-01-05 US disclosed
US-9358226-B2 Triarylmethane analogs and their use in treating cancers EMORY UNIVERSITY (US) 2016-06-07 US disclosed
EP-2237785-B1 TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS UNIV EMORY (US) 2015-12-23 EP disclosed
US-20130333758-A1 PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL AND SOLAR CELL MODULE MITSUBISHI CHEMICAL CORPORATION (JP) 2013-12-19 US disclosed
EP-2669966-A1 PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND SOLAR CELL MODULE Mitsubishi Chemical Corporation (JP) 2013-12-04 EP disclosed
US-8435979-B2 Use of imipramine blue and analogs thereof in treating cancers EMORY UNIVERSITY (US) 2013-05-07 US disclosed
WO-2003082301-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER THRESHOLD PHARMACEUTICALS, INC. (US) 2003-10-09 WO disclosed
WO-2002034711-A1 BIARYL COMPOUNDS AS SERINE PROTEASE INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2002-05-02 WO disclosed
EP-1192165-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES Bristol-Myers Squibb Pharma Company (US) 2002-04-03 EP disclosed
WO-2000077010-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES DU PONT PHARMACEUTICALS COMPANY (US) 2000-12-21 WO disclosed
JP-2000256305-A PRODUCTION OF OPTICALLY ACTIVE AMINE COMPOUND SUMITOMO CHEM CO LTD 2000-09-19 JP disclosed
WO-1993000357-A1 THERAPEUTIC POLYPEPTIDES BASED ON VON WILLEBRAND FACTOR RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1993-01-07 WO disclosed
EP-0001717-B1 INSECTICIDAL COMPOSITIONS CONTAINING TETRAORGANOTIN COMPOUNDS AND METHOD FOR USING SAME M & T CHEMICALS, INC. (US) 1981-11-04 EP disclosed
US-4212885-A Insecticidal compositions containing certain tetraorganotin compounds and method for using same M&T CHEMICALS INC. (US) 1980-07-15 US disclosed
EP-0001717-A2 Insecticidal compositions containing tetraorganotin compounds and method for using same M & T CHEMICALS, INC. (US) 1979-05-02 EP disclosed
US-4138483-A Insecticidal compositions containing certain tetraorganotin compounds and method for using same M&T CHEMICALS INC. (US) 1979-02-06 US disclosed